CRA International Q1 revenue rises 10.5%, beats estimates

CRA International, Inc.

CRA International, Inc.

CRAI

0.00


Overview

  • US consulting firm's fiscal Q1 revenue rose 10.5% yr/yr, beating analyst expectations

  • Adjusted EPS for fiscal Q1 missed consensus, declining 10.4% yr/yr

  • Company returned $25.3 mln to shareholders via dividends and share repurchases


Outlook

  • CRA International reaffirms full-year 2026 revenue guidance of $785 mln to $805 mln

  • Company expects 2026 non-GAAP EBITDA margin of 12.0% to 13.0%


Result Drivers

  • BROAD-BASED PRACTICE GROWTH - Eight practices grew yr/yr, with Energy, Finance, Forensic Services, and Life Sciences posting double-digit revenue growth; Antitrust & Competition Economics set a new quarterly revenue record

  • GEOGRAPHIC EXPANSION - Revenue grew across geographies, with North America up 8.5% and international operations up 20.3% yr/yr

  • PORTFOLIO OPTIMIZATION COSTS - Net income decline partly reflected $2.6 mln in cash severance and non-cash charges tied to portfolio optimization actions


Company press release: ID:nBw42MCrYa


Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q1 Revenue

Beat

$201 mln

$193.82 mln (3 Analysts)

Q1 Adjusted EPS

Miss

$1.99

$2.02 (3 Analysts)

Q1 EPS

$1.69

Q1 Adjusted Net Income

$13.10 mln

Q1 Net Income

$11.10 mln


Analyst Coverage

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 1 "strong buy" or "buy", 1 "hold" and no "sell" or "strong sell"

  • Wall Street's median 12-month price target for CRA International Inc is $252.50, about 65.4% above its May 6 closing price of $152.64

  • The stock recently traded at 17 times the next 12-month earnings vs. a P/E of 21 three months ago


For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.